{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:52:28Z","timestamp":1790509948771,"version":"4.1.0"},"reference-count":152,"publisher":"Elsevier","isbn-type":[{"value":"9780128167540","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.irn.2019.06.012","type":"book-chapter","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:06:44Z","timestamp":1561720004000},"page":"229-257","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders"],"prefix":"10.1016","author":[{"given":"Mario","family":"Antonazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harkaitz","family":"Bengoetxea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 \u00c1ngel","family":"Ruiz-Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Morera-Herreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00580-014-1907-9","article-title":"The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats","volume":"24","author":"Abdel-Salam","year":"2015","journal-title":"Comparative Clinical Pathology"},{"key":"10.1016\/bs.irn.2019.06.012_bb0015","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s12035-018-1129-2","article-title":"The pharmacological inhibition of fatty acid amide hydrolase prevents excitotoxic damage in the rat striatum: Possible involvement of CB1 receptors regulation","volume":"56","author":"Aguilera-Portillo","year":"2019","journal-title":"Molecular Neurobiology"},{"issue":"8","key":"10.1016\/bs.irn.2019.06.012_bb0020","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00702-013-1149-z","article-title":"A further update on the role of excitotoxicity in the pathogenesis of Parkinson's disease","volume":"121","author":"Ambrosi","year":"2014","journal-title":"Journal of Neural Transmission"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0025","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/ijms19113543","article-title":"Inhibition of microglia-derived oxidative stress by ciliary neurotrophic factor protects dopamine neurons in vivo from MPP+ neurotoxicity","volume":"19","author":"Baek","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0030","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s12035-016-9731-7","article-title":"Arachidonyl-2-Chloroethylamide alleviates cerebral ischemia injury through glycogen synthase kinase-3\u03b2-mediated mitochondrial biogenesis and functional improvement","volume":"54","author":"Bai","year":"2017","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/01.wnl.0000267407.79757.75","article-title":"Endocannabinoids in basal ganglia circuits: Implications for Parkinson disease","volume":"69","author":"Benarroch","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0040","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1531-8257(199905)14:3<398::AID-MDS1003>3.0.CO;2-F","article-title":"Pathophysiology of chorea and bradykinesia in Huntington's disease","volume":"14","author":"Berardelli","year":"1999","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2019.06.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202566","article-title":"Cannabinoid 1 receptor signaling on GABAergic neurons influences astrocytes in the ageing brain","volume":"13","author":"Bilkei-Gorzo","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuint.2007.06.031","article-title":"Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6\/2 mice, a transgenic model of Huntington's disease","volume":"52","author":"Bisogno","year":"2008","journal-title":"Neurochemistry International"},{"issue":"10","key":"10.1016\/bs.irn.2019.06.012_bb0060","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/cdd.2015.11","article-title":"The CB1cannabinoid receptor signals striatal neuroprotection via a PI3K\/Akt\/mTORC1\/BDNF pathway","volume":"22","author":"Bl\u00e1zquez","year":"2015","journal-title":"Cell Death and Differentiation"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Bl\u00e1zquez","year":"2011","journal-title":"Brain"},{"issue":"22","key":"10.1016\/bs.irn.2019.06.012_bb0070","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00018-006-6242-0","article-title":"Huntington's disease: From huntingtin function and dysfunction to therapeutic strategies","volume":"63","author":"Borrell-Pag\u00e8s","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"50","key":"10.1016\/bs.irn.2019.06.012_bb0075","doi-asserted-by":"crossref","first-page":"18259","DOI":"10.1523\/JNEUROSCI.4008-12.2012","article-title":"Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease","volume":"32","author":"Bouchard","year":"2012","journal-title":"Journal of Neuroscience"},{"issue":"12","key":"10.1016\/bs.irn.2019.06.012_bb0080","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/syn.20569","article-title":"Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus","volume":"62","author":"Brusco","year":"2008","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/sj.bjp.0707584","article-title":"CB 2 receptors in the brain: Role in central immune function","volume":"153","author":"Cabral","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/bs.irn.2019.06.012_bb0090","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/bja\/aex267","article-title":"Activation of cannabinoid receptor 1 is involved in protection against mitochondrial dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning","volume":"119","author":"Cai","year":"2017","journal-title":"British Journal of Anaesthesia"},{"issue":"8","key":"10.1016\/bs.irn.2019.06.012_bb0095","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: A critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nature Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2019.06.012_bb0100","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2990.2011.01248.x","article-title":"\u03949-tetrahydrocannabinol (\u03949-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease","volume":"38","author":"Carroll","year":"2012","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0105","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB2and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/bs.irn.2019.06.012_bb0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/NEN.0000000000000064","article-title":"Neuroprotective potential of adenosine A2Aand cannabinoid CB1receptor antagonists in an animal model of Parkinson disease","volume":"73","author":"Cerri","year":"2014","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0120","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881114550355","article-title":"Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial","volume":"28","author":"Chagas","year":"2014","journal-title":"Journal of Psychopharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0125","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-3565(24)39301-2","article-title":"Cannabinoids protect cells from oxidative cell death: A receptor-independent mechanism","volume":"293","author":"Chen","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.RES.87.4.323","article-title":"Human brain capillary endothelium: 2-Arachidonoglycerol (endocannabinoid) interacts with endothelin-1","volume":"87","author":"Chen","year":"2000","journal-title":"Circulation Research"},{"issue":"22","key":"10.1016\/bs.irn.2019.06.012_bb0135","doi-asserted-by":"crossref","first-page":"8257","DOI":"10.1073\/pnas.1400988111","article-title":"A restricted population of CB1 cannabinoid receptors with neuroprotective activity","volume":"111","author":"Chiarlone","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/bs.irn.2019.06.012_bb0140","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.4049\/jimmunol.1102435","article-title":"Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation","volume":"187","author":"Chung","year":"2011","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0145","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1038\/emm.2015.100","article-title":"CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson's disease","volume":"48","author":"Chung","year":"2016","journal-title":"Experimental and Molecular Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0150","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neuroscience.2007.11.047","article-title":"Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain","volume":"151","author":"Cristino","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2019.06.012_bb0155","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuroscience.2014.01.049","article-title":"Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus","volume":"265","author":"Dasilva","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2019.06.012_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0306-4522(00)00157-3","article-title":"Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice","volume":"98","author":"Denovan-Wright","year":"2000","journal-title":"Neuroscience"},{"issue":"5090","key":"10.1016\/bs.irn.2019.06.012_bb0170","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0175","doi-asserted-by":"crossref","first-page":"29789","DOI":"10.1038\/srep29789","article-title":"VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease","volume":"6","author":"D\u00edaz-Alonso","year":"2016","journal-title":"Scientific Reports"},{"issue":"21","key":"10.1016\/bs.irn.2019.06.012_bb0180","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1523\/JNEUROSCI.0372-06.2006","article-title":"Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission","volume":"26","author":"Domenici","year":"2006","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0185","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.neuroscience.2009.06.014","article-title":"Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease","volume":"163","author":"Dowie","year":"2009","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0190","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s12640-016-9698-1","article-title":"URB597 and the cannabinoid WIN55,212-2 reduce behavioral and neurochemical deficits induced by MPTP in mice: Possible role of redox modulation and NMDA receptors","volume":"31","author":"Escamilla-Ram\u00edrez","year":"2017","journal-title":"Neurotoxicity Research"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.06.012_bb0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in \u03b2-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-\u03baB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neuroscience Letters"},{"issue":"8","key":"10.1016\/bs.irn.2019.06.012_bb0200","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts \u03b2-amyloid induced neuroinflammation by suppressing IL-1\u03b2 and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2019.06.012_bb0205","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.mie.2017.06.021","article-title":"Modeling neurodegenerative disorders for developing cannabinoid-based neuroprotective therapies","volume":"Vol. 593","author":"Fern\u00e1ndez-Ruiz","year":"2017"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0210","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2010","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"7","key":"10.1016\/bs.irn.2019.06.012_bb0215","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","article-title":"Prospects for cannabinoid therapies in basal ganglia disorders","volume":"163","author":"Fern\u00e1ndez-Ruiz","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"1\u20132 Suppl. 1","key":"10.1016\/bs.irn.2019.06.012_bb0220","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.mce.2008.01.001","article-title":"Role of CB2receptors in neuroprotective effects of cannabinoids","volume":"286","author":"Fern\u00e1ndez-Ruiz","year":"2008","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.irn.2019.06.012_bb0225","series-title":"Endocannabinoids","first-page":"233","article-title":"Endocannabinoids and neurodegenerative disorders: Parkinson's disease, Huntington's chorea, Alzheimer's disease, and others","author":"Fern\u00e1ndez-Ruiz","year":"2015"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0230","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","article-title":"Cannabinoid CB2receptor: A new target for controlling neural cell survival?","volume":"28","author":"Fern\u00e1ndez-Ruiz","year":"2007","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fern\u00e1ndez-Ruiz","year":"2013","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0240","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.neurobiolaging.2014.05.021","article-title":"The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model","volume":"35","author":"Fern\u00e1ndez-Su\u00e1rez","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"6","key":"10.1016\/bs.irn.2019.06.012_bb0245","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1046\/j.1460-9568.2003.02896.x","article-title":"Effects of levodopa on endocannabinoid levels in rat basal ganglia: Implications for the treatment of levodopa-induced dyskinesias","volume":"18","author":"Ferrer","year":"2003","journal-title":"European Journal of Neuroscience"},{"issue":"24","key":"10.1016\/bs.irn.2019.06.012_bb0250","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2174\/0929867321666140303143455","article-title":"Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPAR\u03b1) and its lipid ligands","volume":"21","author":"Fidaleo","year":"2014","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0255","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pnpbp.2011.12.004","article-title":"Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output","volume":"38","author":"Fitzgerald","year":"2012","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2019.06.012_bb0260","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0006-2952(03)00392-7","article-title":"Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: Variability in response and involvement of arachidonic acid","volume":"66","author":"Fowler","year":"2003","journal-title":"Biochemical Pharmacology"},{"issue":"13","key":"10.1016\/bs.irn.2019.06.012_bb0265","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.2174\/09298673113209990112","article-title":"Rationally designed multi-targeted agents against neurodegenerative diseases","volume":"20","author":"Geldenhuys","year":"2013","journal-title":"Current Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0270","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"Journal of Neurophysiology"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0275","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-neuro-061010-113641","article-title":"Modulation of striatal projection systems by dopamine","volume":"34","author":"Gerfen","year":"2011","journal-title":"Annual Review of Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0280","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0285","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0306-4522(03)00595-5","article-title":"Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors","volume":"123","author":"Glass","year":"2004","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","article-title":"Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain","volume":"1071","author":"Gong","year":"2006","journal-title":"Brain Research"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0295","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1460-9568.2004.03428.x","article-title":"Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala","volume":"20","author":"Gulyas","year":"2004","journal-title":"European Journal of Neuroscience"},{"issue":"14","key":"10.1016\/bs.irn.2019.06.012_bb0300","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212) 9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0305","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1471-4159.2002.00961.x","article-title":"Blockade of cannabinoid CB1receptor function protects against in vivo disseminating brain damage following NMDA-induced excitotoxicity","volume":"82","author":"Hansen","year":"2002","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/bs.irn.2019.06.012_bb0310","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1523\/JNEUROSCI.4159-06.2007","article-title":"Presynaptic Monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the Hippocampus","volume":"27","author":"Hashimotodani","year":"2007","journal-title":"Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0315","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neuroscience Letters"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0320","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00310376","article-title":"Cortical and striatal neurone number in Huntington's disease","volume":"88","author":"Heinsen","year":"1994","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0325","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB1receptor mRNA in neuronal subpopulations of rat striatum: A double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1755-5949.2008.00065.x","article-title":"Cannabidiol: A promising drug for neurodegenerative disorders?","volume":"15","author":"Iuvone","year":"2009","journal-title":"CNS Neuroscience and Therapeutics"},{"key":"10.1016\/bs.irn.2019.06.012_bb0335","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fnins.2016.00321","article-title":"Cannabinoid type 2 (CB2) receptors activation protects against oxidative stress and neuroinflammation associated dopaminergic neurodegeneration in rotenone model of parkinson's disease","volume":"10","author":"Javed","year":"2016","journal-title":"Frontiers in Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0340","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/glia.22560","article-title":"The G protein-coupled receptor 55 ligand l-\u03b1-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion","volume":"61","author":"Kallendrusch","year":"2013","journal-title":"Glia"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0345","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/jpet.107.120147","article-title":"Endocannabinoid enhancement protects against Kainic acid-induced seizures and associated brain damage","volume":"322","author":"Karanian","year":"2007","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"9","key":"10.1016\/bs.irn.2019.06.012_bb0350","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm.f.1869","article-title":"Endocannabinoid signaling as a synaptic circuit breaker in neurological disease","volume":"14","author":"Katona","year":"2008","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.irn.2019.06.012_bb0355","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jns.2017.08.3251","article-title":"Neuroinflammation\u2014a major cause for striatal dopaminergic degeneration in Parkinson's disease","volume":"381","author":"Kaur","year":"2017","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"10.1016\/bs.irn.2019.06.012_bb0360","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1460-9568.2004.03285.x","article-title":"Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity","volume":"19","author":"Khaspekov","year":"2004","journal-title":"European Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0365","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1523\/JNEUROSCI.4166-04.2005","article-title":"Transient receptor potential Vanilloid subtype 1 mediates cell death of mesencephalic dopaminergic neurons in vivo and in vitro","volume":"25","author":"Kim","year":"2005","journal-title":"Journal of Neuroscience"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0370","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1523\/JNEUROSCI.4232-04.2005","article-title":"Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: A combined immunochemical and pharmacological analysis","volume":"25","author":"Kofalvi","year":"2005","journal-title":"Journal of Neuroscience"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/0269881110367732","article-title":"Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis","volume":"25","author":"Lanciego","year":"2011","journal-title":"Journal of Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.06.012_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jneuroim.2013.12.008","article-title":"The cytokine and endocannabinoid systems are co-regulated by NF-\u03baB p65\/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients","volume":"267","author":"Laprairie","year":"2014","journal-title":"Journal of Neuroimmunology"},{"issue":"15","key":"10.1016\/bs.irn.2019.06.012_bb0385","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1097\/00001756-200410250-00015","article-title":"Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo","volume":"15","author":"Lastres-Becker","year":"2004","journal-title":"Neuroreport"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.06.012_bb0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0395","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/tp.2012.15","article-title":"Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia","volume":"2","author":"Leweke","year":"2012","journal-title":"Translational Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0400","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11064-014-1474-0","article-title":"Neuroprotective effects of trans-Caryophyllene against Kainic acid induced seizure activity and oxidative stress in mice","volume":"40","author":"Liu","year":"2014","journal-title":"Neurochemical Research"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0405","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12974-018-1174-9","article-title":"Cannabinoid CB2receptors in the mouse brain: Relevance for Alzheimer's disease","volume":"15","author":"L\u00f3pez","year":"2018","journal-title":"Journal of Neuroinflammation"},{"issue":"7","key":"10.1016\/bs.irn.2019.06.012_bb0410","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00415-016-8145-9","article-title":"A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease","volume":"263","author":"L\u00f3pez-Send\u00f3n Moreno","year":"2016","journal-title":"Journal of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0415","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0420","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1038\/srep12440","article-title":"Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions","volume":"5","author":"Ma","year":"2015","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/bs.irn.2019.06.012_bb0425","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"MacDonald","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0430","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0306-4522(92)90409-U","article-title":"Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry","volume":"48","author":"Mailleux","year":"1992","journal-title":"Neuroscience"},{"key":"10.1016\/bs.irn.2019.06.012_bb0435","doi-asserted-by":"crossref","first-page":"130639","DOI":"10.1155\/2015\/130639","article-title":"Anandamide, acting via CB2 receptors, alleviates LPS-induced neuroinflammation in rat primary microglial cultures","volume":"2015","author":"Malek","year":"2015","journal-title":"Neural Plasticity"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0440","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.0022-3042.2001.00716.x","article-title":"Neuroprotective properties of cannabinoids against oxidative stress: Role of the cannabinoid receptor CB1","volume":"80","author":"Marsicano","year":"2002","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"10.1016\/bs.irn.2019.06.012_bb0445","doi-asserted-by":"crossref","first-page":"a008870","DOI":"10.1101\/cshperspect.a008870","article-title":"Clinical approach to Parkinson's disease: Features, diagnosis, and principles of management","volume":"2","author":"Massano","year":"2012","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0450","first-page":"261","article-title":"Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in the rat brain: Involvement of CB1 and NMDA receptors","volume":"9","author":"Maya-L\u00f3pez","year":"2017","journal-title":"American Journal of Translational Research"},{"key":"10.1016\/bs.irn.2019.06.012_bb0455","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.biopha.2017.01.116","article-title":"URB597 reduces biochemical, behavioral and morphological alterations in two neurotoxic models in rats","volume":"88","author":"Maya-L\u00f3pez","year":"2017","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"23\u201324","key":"10.1016\/bs.irn.2019.06.012_bb0460","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1111\/j.1432-1033.2004.04460.x","article-title":"Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice","volume":"271","author":"McCaw","year":"2004","journal-title":"European Journal of Biochemistry"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0465","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","article-title":"Cannabinoids and brain injury: Therapeutic implications","volume":"8","author":"Mechoulam","year":"2002","journal-title":"Trends in Molecular Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2019.06.012_bb0470","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1073\/pnas.97.7.3655","article-title":"Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human","volume":"97","author":"Mezey","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0475","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.irn.2019.06.012_bb0480","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fphar.2012.00110","article-title":"Endocannabinoid modulation of dopaminergic motor circuits","volume":"3","author":"Morera-Herreras","year":"2012","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0485","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/syn.21796","article-title":"Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry","volume":"69","author":"Mu\u00f1oz-Arenas","year":"2015","journal-title":"Synapse"},{"issue":"6441","key":"10.1016\/bs.irn.2019.06.012_bb0490","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.06.012_bb0495","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(93)90804-V","article-title":"Blockade of45Ca2+influx through the N-methyl-d-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211","volume":"622","author":"Nadler","year":"1993","journal-title":"Brain Research"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0500","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12031-010-9472-4","article-title":"A new generation fatty acid amide hydrolase inhibitor protects against kainate-induced excitotoxicity","volume":"43","author":"Naidoo","year":"2011","journal-title":"Journal of Molecular Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13311-018-0603-x","article-title":"Cannabinoid CB1 and CB2 receptors, and Monoacylglycerol lipase gene expression alterations in the basal ganglia of patients with Parkinson's disease","volume":"15","author":"Navarrete","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"Sep","key":"10.1016\/bs.irn.2019.06.012_bb0510","first-page":"406","article-title":"Targeting cannabinoid CB2receptors in the central nervous system. Medicinal chemistry approaches with focus on neurodegenerative disorders","volume":"10","author":"Navarro","year":"2016","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2019.06.012_bb0515","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nbd.2014.08.009","article-title":"Genetic rescue of CB1receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice","volume":"71","author":"Naydenov","year":"2014","journal-title":"Neurobiology of Disease"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0520","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroscience.2007.10.029","article-title":"Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome","volume":"151","author":"N\u00fa\u00f1ez","year":"2008","journal-title":"Neuroscience"},{"issue":"14","key":"10.1016\/bs.irn.2019.06.012_bb0525","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1056\/NEJM2003ra020003","article-title":"Alzheimer's disease and Parkinson's disease","volume":"348","author":"Nussbaum","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/bs.irn.2019.06.012_bb0530","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1111\/bph.13497","article-title":"An update on PPAR activation by cannabinoids","volume":"173","author":"O\u2019Sullivan","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0535","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neulet.2010.03.026","article-title":"Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-\u03baB activation in BV2 murine microglial cells","volume":"474","author":"Oh","year":"2010","journal-title":"Neuroscience Letters"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2019.06.012_bb0540","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-016-2733-y","article-title":"\u03b2-Caryophyllene, a phytocannabinoid attenuates oxidative stress, neuroinflammation, glial activation, and salvages dopaminergic neurons in a rat model of Parkinson disease","volume":"418","author":"Ojha","year":"2016","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0545","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","article-title":"Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain","volume":"1074","author":"Onaivi","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0550","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0555","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1093\/brain\/awp239","article-title":"Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity","volume":"132","author":"Palazuelos","year":"2009","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2019.06.012_bb0560","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1Aand CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.irn.2019.06.012_bb0565","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2016.04.068","article-title":"URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats","volume":"624","author":"Peli\u00e7\u00e3o","year":"2016","journal-title":"Neuroscience Letters"},{"issue":"5","key":"10.1016\/bs.irn.2019.06.012_bb0570","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.neuropharm.2006.06.013","article-title":"The cannabinoid receptor agonist WIN 55,212-2 attenuates the effects induced by quinolinic acid in the rat striatum","volume":"51","author":"Pintor","year":"2006","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0575","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nature Reviews Neuroscience"},{"issue":"Suppl. 4","key":"10.1016\/bs.irn.2019.06.012_bb0580","first-page":"S28","article-title":"The clinical progression of Parkinson's disease","volume":"15","author":"Poewe","year":"2010","journal-title":"Parkinsonism & Related Disorders"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0585","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1111\/j.1460-9568.2009.06764.x","article-title":"WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"29","author":"Price","year":"2009","journal-title":"European Journal of Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2019.06.012_bb0590","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer's disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2019.06.012_bb0595","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.expneurol.2013.05.014","article-title":"A survey from 2012 of evidence for the role of neuroinflammation in neurotoxin animal models of Parkinson's disease and potential molecular targets","volume":"256","author":"Ramsey","year":"2014","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.irn.2019.06.012_bb0600","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2014.11.016","article-title":"Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain","volume":"285","author":"Rangel-L\u00f3pez","year":"2015","journal-title":"Neuroscience"},{"issue":"15","key":"10.1016\/bs.irn.2019.06.012_bb0605","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0610","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00253-X","article-title":"The endogenous cannabinoid system and the basal ganglia: Biochemical, pharmacological, and therapeutic aspects","volume":"95","author":"Romero","year":"2002","journal-title":"Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3233\/JHD-170283","article-title":"Cannabinoids for treatment of dystonia in Huntington's disease","volume":"7","author":"Saft","year":"2018","journal-title":"Journal of Huntington's Disease"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0620","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12035-007-0004-3","article-title":"Cannabinoids and neuroprotection in basal ganglia disorders","volume":"36","author":"Sagredo","year":"2007","journal-title":"Molecular Neurobiology"},{"issue":"11","key":"10.1016\/bs.irn.2019.06.012_bb0625","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/glia.20838","article-title":"Cannabinoid CB2receptor agonists protect the striatum against malonate toxicity: Relevance for Huntington's disease","volume":"57","author":"Sagredo","year":"2009","journal-title":"Glia"},{"issue":"9","key":"10.1016\/bs.irn.2019.06.012_bb0630","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/jnr.22682","article-title":"Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington's disease","volume":"89","author":"Sagredo","year":"2011","journal-title":"Journal of Neuroscience Research"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0635","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"The Lancet Neurology"},{"issue":"9942","key":"10.1016\/bs.irn.2019.06.012_bb0640","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: Future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/bs.irn.2019.06.012_bb0645","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPAR\u03b3 involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytotherapy Research"},{"key":"10.1016\/bs.irn.2019.06.012_bb0650","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neuint.2015.06.005","article-title":"Combined neuroprotective action of adenosine A1and cannabinoid CB1receptors against NMDA-induced excitotoxicity in the hippocampus","volume":"87","author":"Serpa","year":"2015","journal-title":"Neurochemistry International"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0655","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11481-009-9147-5","article-title":"WIN55,212-2 inhibits production of CX3CL1 by human astrocytes: Involvement of p38 MAP kinase","volume":"4","author":"Sheng","year":"2009","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"5","key":"10.1016\/bs.irn.2019.06.012_bb0660","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00429-014-0823-8","article-title":"Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: Changes following experimental parkinsonism","volume":"220","author":"Sierra","year":"2015","journal-title":"Brain Structure and Function"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0665","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0022-3565(24)39213-4","article-title":"Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice","volume":"293","author":"Smith","year":"2000","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.irn.2019.06.012_bb0670","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2006.03880.x","article-title":"Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats","volume":"98","author":"Solinas","year":"2006","journal-title":"Journal of Neurochemistry"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0675","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.01.005","article-title":"Biochemistry and pharmacology of endovanilloids","volume":"114","author":"Starowicz","year":"2007","journal-title":"Pharmacology and Therapeutics"},{"issue":"5","key":"10.1016\/bs.irn.2019.06.012_bb0680","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/bs.irn.2019.06.012_bb0685","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.redox.2016.12.029","article-title":"Cannabidiol attenuates OGD\/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons","volume":"11","author":"Sun","year":"2017","journal-title":"Redox Biology"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0690","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.neuroscience.2006.01.024","article-title":"The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus","volume":"139","author":"Takahashi","year":"2006","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2019.06.012_bb0695","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.neuron.2010.01.021","article-title":"The endocannabinoid 2-Arachidonoylglycerol produced by diacylglycerol lipase \u03b1 mediates retrograde suppression of synaptic transmission","volume":"65","author":"Tanimura","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0700","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-004-0944-0","article-title":"Cellular pathology of Parkinson's disease: Astrocytes, microglia and inflammation","volume":"318","author":"Teismann","year":"2004","journal-title":"Cell and Tissue Research"},{"issue":"9","key":"10.1016\/bs.irn.2019.06.012_bb0705","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1089\/ars.2009.2697","article-title":"Parkinson's disease: From molecular pathways in disease to therapeutic approaches","volume":"11","author":"Thomas","year":"2009","journal-title":"Antioxidants & Redox Signaling"},{"issue":"1\u20133","key":"10.1016\/bs.irn.2019.06.012_bb0710","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2003.08.101","article-title":"The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: Implications for neurological and psychiatric disorders","volume":"480","author":"van der Stelt","year":"2003","journal-title":"European Journal of Pharmacology"},{"issue":"17","key":"10.1016\/bs.irn.2019.06.012_bb0715","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1523\/JNEUROSCI.21-17-06475.2001","article-title":"Neuroprotection by \u03949-tetrahydrocannabinol, the main active compound in marijuana, against Ouabain-induced in vivo excitotoxicity","volume":"21","author":"van der Stelt","year":"2001","journal-title":"The Journal of Neuroscience"},{"issue":"2\u20133","key":"10.1016\/bs.irn.2019.06.012_bb0720","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1385\/MN:26:2-3:317","article-title":"Acute neuronal injury, excitotoxicity, and the endocannabinoid system","volume":"26","author":"van der Stelt","year":"2002","journal-title":"Molecular Neurobiology"},{"issue":"9","key":"10.1016\/bs.irn.2019.06.012_bb0725","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"5746","key":"10.1016\/bs.irn.2019.06.012_bb0730","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Neuroscience: Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.irn.2019.06.012_bb0735","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1124\/jpet.105.095059","article-title":"Fatty acid amide hydrolase (\u2212\/\u2212) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task","volume":"317","author":"Varvel","year":"2006","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"10","key":"10.1016\/bs.irn.2019.06.012_bb0740","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1523\/JNEUROSCI.23-10-04127.2003","article-title":"Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: Role of vanilloid receptors and lipoxygenases","volume":"23","author":"Veldhuis","year":"2003","journal-title":"The Journal of Neuroscience"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0745","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s12640-017-9839-1","article-title":"Cannabinoid receptor type 1 agonist ACEA protects neurons from death and attenuates endoplasmic reticulum stress-related apoptotic pathway signaling","volume":"33","author":"Vrechi","year":"2018","journal-title":"Neurotoxicity Research"},{"issue":"4","key":"10.1016\/bs.irn.2019.06.012_bb0750","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","article-title":"Nonpsychotropic cannabinoid receptors regulate microglial cell migration","volume":"23","author":"Walter","year":"2003","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2019.06.012_bb0755","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2013.12.026","article-title":"Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy","volume":"68","author":"Yang","year":"2014","journal-title":"Free Radical Biology and Medicine"},{"issue":"29","key":"10.1016\/bs.irn.2019.06.012_bb0760","doi-asserted-by":"crossref","first-page":"46603","DOI":"10.18632\/oncotarget.10314","article-title":"Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis","volume":"7","author":"Zeissler","year":"2016","journal-title":"Oncotarget"},{"issue":"46","key":"10.1016\/bs.irn.2019.06.012_bb0765","doi-asserted-by":"crossref","first-page":"E5007","DOI":"10.1073\/pnas.1413210111","article-title":"Cannabinoid CB 2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice","volume":"111","author":"Zhang","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"}],"container-title":["International Review of Neurobiology","New Therapeutic Strategies for Brain Edema and Cell Injury"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774219300327?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774219300327?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T12:48:52Z","timestamp":1786798132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774219300327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9780128167540"],"references-count":152,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2019.06.012","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}